All In Biotech

Drug Trial Radar · NCT01381796

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

A Phase I, Single Center, Open Label, Randomized, Single-Dose, Three-Way Crossover Study to Compare the Pharmacokinetics and Bioavailability of Two NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex in Healthy Volunteers and to Collect Resistance Data During Application of NP101

Last checked: Nov 19, 2026Latest source record: Oct 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

Dec 2009

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
NuPathe Inc.Industry
Sponsor type
Industry
First posted
Jun 27, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research is to: 1. Compare two study patches having minor differences in patch components 2. Compare the pharmacokinetics (PK - how the body absorbs, metabolizes and eliminates medication) of NP101 (study patches) versus a currently approved oral formulation of Imitrex 3. Collect resistance data during application of NP101 (study patch)

Conditions

  • Compare Bioequivalence Patches Previously Used in the NP101-007 Study

Interventions

  • NP101Drug

    comparison of NP101 with minor patch modifications

  • sumatriptan succinateDrug

    tablet, 100 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Analysis of variance (ANOVA) will be used to compare AUC0-inf and Cmax values between treatments. AUC0-last, Tmax and t1/2 will be summarized descriptively.Time frame: Blood samples (4 mL per sample) for PK analysis will be collected for all treatments by catheter or venipuncture into EDTA collection tubes for the determination of sumatriptan concentrations in plasma for each treatment.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Prism Research, LLC

    Saint Paul, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.